No Association Between Hospital-Reported Perioperative Venous Thromboembolism Prophylaxis and Outcome Rates in Publicly Reported Data
Venous thromboembolism (VTE), consisting of deep vein thrombosis (DVT) and pulmonary embolism, is an important cause of postoperative mortality and long-term morbidity. Because many events are preventable, VTE prophylaxis performance and postoperative VTE are used as measures of hospital quality of care and patient safety. Two such metrics are reported on the Centers for Medicare & Medicaid Services Hospital Compare website (http://www .medicare.gov/hospitalcompare/search.html) with the stated goal of helping consumers make decisions about where to receive their health care.
The Surgical Care Improvement Project (SCIP) VTE-2, a process measure, captures the percentage of a hospital's surgical patients who received any VTE prophylaxis within 24 hours of surgery. Previous studies have shown that performance on the SCIP VTE-2 measure is not associated with VTE among Medicare patients in 6 high-risk surgical procedures, 1 Methods | The SCIP VTE-2 and PSI-12 data were downloaded from the Centers for Medicare & Medicaid Services website. Average annual prophylaxis performance was linked to the 2-year VTE rate for each hospital (from July 1, 2009, to June 30, 2011). The PSI-12 is adjusted for age, sex, age × sex interactions, diagnosis-related group, and modified comorbidity index prior to public reporting. Simple linear regression was used to test for an association between VTE prophylaxis and VTE rate. Sensitivity analyses were performed that excluded outliers and that used a log-transformed VTE rate because the data were not normally distributed. Hospitals were categorized by quintile of prophylaxis performance, and VTE rates were compared using a nonparametric Kruskal-Wallis rank test and Bonferroni-corrected rank sum tests for multiple pairwise comparisons. Hospitals with 100% prophylaxis performance were compared to the lowest quintile using a rank sum test. Statistical analyses were conducted using Stata version 11.2 (StataCorp).
Results | There were 3040 hospitals with complete prophylaxis and VTE data. Average annual prophylaxis performance was negatively skewed (median rate, 94.5%). The median riskadjusted VTE rate was 4.13 per 1000 surgical discharges. Prophylaxis performance was not associated with VTE rate (P = .13) on linear regression (Figure 1) . Regression results were unchanged in sensitivity analyses that excluded outliers (P = .51) and that used a log-transformed VTE rate (P = .90). Among quintiles, the VTE rates appeared to be similar ( Figure 2) . Although the global Kruskal-Wallis test was significant (P = .04), no pairwise comparison by quintile was statistically significant. Hospitals reporting 100% VTE prophylaxis performance (n = 141) and hospitals in the bottom quintile of prophylaxis performance (n = 618) had nearly identical median VTE outcome rates (4.18 vs 4.17; P = .98, determined by rank sum test).
Discussion | Our findings show that there is no association between reported VTE prophylaxis and outcome rates for surgical patients, when compared across the range of process measure performance. There was no difference in quintiles, or between extremes at 100% performance and the lowest quintile. This may reflect the current low, minimum standard for VTE prophylaxis because the SCIP VTE-2 gives credit for even the most basic, suboptimal prophylaxis. Perhaps a more rigorously applied benchmark to report adherence to optimal, risk-appropriate prophylaxis would have a 
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Uncertainty in Management of Carotid Stenosis in Women
To the Editor A review of the "management of carotid stenosis in women" has recently been performed by Kuy and collaborators 1 with the aim of defining the burden of carotid disease and providing guidelines for the management of carotid stenosis in women. The anticipated increase in the number of strokes in women underscores the importance of this topic. 2 However, the available data on the management of carotid stenosis in women are only partly covered in their review. 
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The Kruskal-Wallis rank test was used to determine the equality of population distributions (P = .04). None of the Bonferroni-corrected rank sum tests for pairwise comparisons of quintiles were statistically significant (all P > .005). The horizontal line in the middle of each box indicates the median, whereas the top and bottom borders of the box mark the 75th and 25th percentiles, respectively. The whiskers above and below the box are Tukey fences marking the most extreme observed values within 1.5 times the interquartile range above the 75th and below the 25th percentiles. AHRQ indicates Agency for Healthcare Research and Quality; PSI, Patient Safety Indicator; SCIP, Surgical Care Improvement Project; and VTE, venous thromboembolism.
